{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T15:38:06Z","timestamp":1722699486914},"reference-count":25,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.vaccine.2006.04.034","type":"journal-article","created":{"date-parts":[[2006,5,23]],"date-time":"2006-05-23T20:49:47Z","timestamp":1148417387000},"page":"5381-5389","source":"Crossref","is-referenced-by-count":8,"title":["Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides"],"prefix":"10.1016","volume":"24","author":[{"given":"Inna G.","family":"Ovsyannikova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Vierkant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5902","key":"10.1016\/j.vaccine.2006.04.034_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/301716a0","article-title":"SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones","volume":"301","author":"Eckels","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2006.04.034_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1017\/S026646230001401X","article-title":"Modern concepts in immune recognition and lymphocyte activation: relevance for the development of useful vaccines","volume":"10","author":"Germain","year":"1994","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.vaccine.2006.04.034_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.1995.tb44444.x","article-title":"The biochemistry and cell biology of antigen presentation by MHC Class I and Class II Molecules","volume":"754","author":"Germain","year":"1998","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2006.04.034_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/JVI.78.1.42-51.2004","article-title":"Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides","volume":"78","author":"Ovsyannikova","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.04.034_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0198-8859(86)90317-4","article-title":"ASHI Workshop Summary Report of the Science and Education Subcommittee: structural and functional relationships of human class II MHC molecules","volume":"15","author":"Eckels","year":"1986","journal-title":"Hum Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.04.034_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0198-8859(87)90086-3","article-title":"Importance of HLA-DQ and -DP restriction elements in T-cell responses to soluble antigens: mutational analysis","volume":"18","author":"Mellins","year":"1987","journal-title":"Hum Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.04.034_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/intimm\/3.9.899","article-title":"HLA polymorphism and T cell recognition of a conserved region of p190, a malaria vaccine candidate","volume":"3","author":"Guttinger","year":"1991","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2006.04.034_bib8","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.humimm.2004.07.001","article-title":"The contribution of HLA class I antigens in immune status following two doses of rubella vaccination","volume":"65","author":"Ovsyannikova","year":"2004","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.04.034_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0042-6822(03)00281-2","article-title":"Naturally processed measles virus peptide eluted from class II HLA-DRB1*03 recognized by T lymphocytes from human blood","volume":"312","author":"Ovsyannikova","year":"2003","journal-title":"Virology"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.04.034_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jim.2004.02.002","article-title":"Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA","volume":"287","author":"Dhiman","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2006.04.034_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/genetics\/50.4.757","article-title":"The interaction of selection and linkage. II. Optimum models","volume":"50","author":"Lewontin","year":"1964","journal-title":"Genetics"},{"issue":"2","key":"10.1016\/j.vaccine.2006.04.034_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/168.2.275","article-title":"Differential CD4 T cell activation in measles","volume":"168","author":"Griffin","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.04.034_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/clin.1993.1061","article-title":"Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response","volume":"67","author":"Ward","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2006.04.034_bib14","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/eji.1830191209","article-title":"Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells","volume":"79","author":"Panina-Bordignon","year":"1989","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2006.04.034_bib15","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1099\/0022-1317-71-9-2099","article-title":"Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans","volume":"71","author":"Partidos","year":"1990","journal-title":"J Gen Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.04.034_bib16","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.4049\/jimmunol.147.11.3893","article-title":"Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules","volume":"147","author":"Sette","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.04.034_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1172\/JCI2860","article-title":"HLA transgenic mice as humanized mouse models of disease and immunity","volume":"101","author":"Taneja","year":"1998","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2006.04.034_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/CDLI.10.3.411-416.2003","article-title":"Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine","volume":"10","author":"Ovsyannikova","year":"2003","journal-title":"Clin Diag Lab Immunol"},{"key":"10.1016\/j.vaccine.2006.04.034_bib19","unstructured":"Sierpe EAG, Keller E, Bettinotti MDLP, et al., Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press; 1992; W3.7, Oligotyping with DRB generic amplified DNA and oligonucleotides 0-25. p. 454-7."},{"issue":"6","key":"10.1016\/j.vaccine.2006.04.034_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/cs0930479","article-title":"Genetic susceptibility to the development of autoimmune disease","volume":"93","author":"Heward","year":"1997","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.vaccine.2006.04.034_bib21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.bi.57.070188.005015","article-title":"Human class II major histocompatibility complex genes and proteins","volume":"57","author":"Kappes","year":"1988","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.vaccine.2006.04.034_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-065X.1982.tb00433.x","article-title":"HLA-D region molecules restrict proliferative T cell responses to antigen","volume":"66","author":"Thorsby","year":"1982","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2006.04.034_bib23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/viro.1997.8678","article-title":"Use of synthetic peptides to identify measles nucleoprotein T-cell epitopes in vaccinated and naturally infected humans","volume":"235","author":"Hickman","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2006.04.034_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1365-2249.1998.00716.x","article-title":"Processing of the DRB1*1103-restricted measles virus nucleoprotein determinant 185\u2013199 in the endosomal compartment","volume":"114","author":"Demotz","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2006.04.034_bib25","first-page":"64","article-title":"HLA-DR\/DQ specific monoclonal antibodies block lympholiferative response to measles vaccine in vitro","volume":"222","author":"Phelan","year":"2001","journal-title":"Mol Aspects Viral Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06004865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06004865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T13:44:23Z","timestamp":1683467063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06004865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":25,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0264410X06004865"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.04.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}